THE ROLE OF FLOT TOTAL NEOADJUVANT CHEMOTHERAPY REGIMEN IN PATIENTS WITH LOCALLY ADVANCED ADENOCARCINOMA OF THE STOMACH AND GASTROESOPHAGEAL JUNCTION. A NARRATIVE REVIEW
Introduction. Gastric cancer is a leading cause of cancer mortality worldwide, and outcomes for patients with locally advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma remain poor. Perioperative chemotherapy became the standard of care after the MAGIC and FNCLCC/FFCD trials demonstrated improved survi...